Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2015 3
2017 1
2018 2
2019 4
2020 5
2021 4
2022 7
2023 3
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer.
Nørgaard M, Rusan M, Kondrup K, Sørensen EMG, Weiss S, Bjerre MT, Fredsøe J, Vang S, Jensen JB, De Laere B, Grönberg H, Borre M, Lindberg J, Sørensen KD. Nørgaard M, et al. Among authors: fredsoe j. J Exp Clin Cancer Res. 2025 Apr 14;44(1):120. doi: 10.1186/s13046-025-03356-0. J Exp Clin Cancer Res. 2025. PMID: 40229848 Free PMC article.
A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer.
Ipsen MB, Sørensen EMG, Thomsen EA, Weiss S, Haldrup J, Dalby A, Palmfeldt J, Bross P, Rasmussen M, Fredsøe J, Klingenberg S, Jochumsen MR, Bouchelouche K, Ulhøi BP, Borre M, Mikkelsen JG, Sørensen KD. Ipsen MB, et al. Among authors: fredsoe j. Oncogene. 2022 Sep;41(37):4271-4281. doi: 10.1038/s41388-022-02427-2. Epub 2022 Aug 6. Oncogene. 2022. PMID: 35933519
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence.
Rasmussen M, Fredsøe J, Tin AL, Vickers AJ, Ulhøi B, Borre M, Eastham J, Ehdaie B, Guillonneau B, Laudone V, Scardino PT, Touijer K, Sørensen KD, Lilja H. Rasmussen M, et al. Among authors: fredsoe j. Br J Cancer. 2022 Apr;126(7):1004-1009. doi: 10.1038/s41416-021-01661-x. Epub 2021 Dec 13. Br J Cancer. 2022. PMID: 34903844 Free PMC article.
Top2 and Sgs1-Top3 Act Redundantly to Ensure rDNA Replication Termination.
Mundbjerg K, Jørgensen SW, Fredsøe J, Nielsen I, Pedersen JM, Bentsen IB, Lisby M, Bjergbaek L, Andersen AH. Mundbjerg K, et al. Among authors: fredsoe j. PLoS Genet. 2015 Dec 2;11(12):e1005697. doi: 10.1371/journal.pgen.1005697. eCollection 2015 Dec. PLoS Genet. 2015. PMID: 26630413 Free PMC article.
32 results